TEYGLOA Trademark

Trademark Overview

On Thursday, July 13, 2023, a trademark application was filed for TEYGLOA with the United States Patent and Trademark Office. The USPTO has given the TEYGLOA trademark a serial number of 98083601. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, April 1, 2024. This trademark is owned by Amgen Inc.. The TEYGLOA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations; pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure
teygloa

General Information

Serial Number98083601
Word MarkTEYGLOA
Filing DateThursday, July 13, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, April 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicespharmaceutical preparations; pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, August 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events

Event DateEvent Description
Monday, April 1, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, April 1, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, December 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 7, 2023NON-FINAL ACTION E-MAILED
Thursday, December 7, 2023NON-FINAL ACTION WRITTEN
Tuesday, December 5, 2023ASSIGNED TO EXAMINER
Sunday, August 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 17, 2023NEW APPLICATION ENTERED

Related Keywords

teygloa preparations pharmaceutical treatment substances disorders diseases blood used inflammatory system